or Try an Advanced Search...

    Technical Analysis for IPSC - Century Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 1.22 -3.17% -0.04
    IPSC closed down 1.56 percent on Wednesday, November 20, 2024, on approximately normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical IPSC trend table...
    Date Alert Name Type % Chg
    Gapped Down Weakness -4.69%
    Inside Day Range Contraction -2.40%
    Wide Bands Range Expansion -2.40%
    MACD Bearish Signal Line Cross Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    20 DMA Resistance Bearish -3.17%
    Wide Bands Range Expansion -3.17%
    Older End-of-Day Signals for IPSC ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 2 hours ago
    60 Minute Opening Range Breakdown about 2 hours ago
    Down 3% about 2 hours ago
    Down 2 % about 3 hours ago
    Down 1% about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IPSC Chart by TradingView
    Basic chart:

    Profile

    Century Therapeutics is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell products are designed to specifically target hematologic and solid tumor cancers. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provides an opportunity to advance the course of cancer care.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Biology Stem Cell Cell Therapy Cell Biology Cancer Care Induced Stem Cells Cloning

    Is IPSC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 8 What Makes Century Therapeutics (IPSC) a New Buy Stock
    Nov 6 Century Therapeutics Third Quarter 2024 Earnings: Beats Expectations
    Nov 5 Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates
    Nov 5 Century Therapeutics Non-GAAP EPS of -$0.37 beats by $0.08, revenue of $0.8M beats by $0.25M
    Nov 5 Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
    Nov 5 Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
    Nov 4 Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
    Oct 28 We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate
    Oct 22 electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar?
    Sep 26 Century Therapeutics taps Morgan Conn as CFO
    See more IPSC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.51
    52 Week Low 1.14
    Average Volume 392,840
    200-Day Moving Average 2.69
    50-Day Moving Average 1.47
    20-Day Moving Average 1.33
    10-Day Moving Average 1.34
    Average True Range 0.12
    RSI (14) 41.18
    ADX 16.57
    +DI 13.23
    -DI 20.42
    Chandelier Exit (Long, 3 ATRs) 1.24
    Chandelier Exit (Short, 3 ATRs) 1.51
    Upper Bollinger Bands 1.51
    Lower Bollinger Band 1.15
    Percent B (%b) 0.3
    BandWidth 26.86
    MACD Line -0.06
    MACD Signal Line -0.06
    MACD Histogram -0.0039
    Fundamentals Value
    Market Cap 75.39 Million
    Num Shares 59.8 Million
    EPS -2.20
    Price-to-Earnings (P/E) Ratio -0.57
    Price-to-Sales 103.41
    Price-to-Book 1.21
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.37
    Resistance 3 (R3) 1.36 1.33 1.35
    Resistance 2 (R2) 1.33 1.30 1.33 1.34
    Resistance 1 (R1) 1.29 1.28 1.30 1.30 1.34
    Pivot Point 1.26 1.26 1.26 1.26 1.26
    Support 1 (S1) 1.22 1.23 1.22 1.22 1.18
    Support 2 (S2) 1.19 1.21 1.19 1.18
    Support 3 (S3) 1.15 1.19 1.17
    Support 4 (S4) 1.15